Objectives: To analyse the mechanisms responsible for multidrug resistance in two carbapenem-resistant Klebsiella pneumoniae isolates recovered from patients hospitalized in Oman.
Introduction
The bla NDM-1 gene is plasmid borne and encodes a metallo-b-lactamase (MBL) that was first identified in Escherichia coli and Klebsiella pneumoniae in Sweden in 2008 from a patient transferred from India. 1 This enzyme hydrolyses all b-lactams except aztreonam and is commonly identified in multidrug-resistant isolates. The rapid emergence of this resistance determinant in a series of multiresistant enterobacterial strains in the UK, India and Pakistan, together with evidence of epidemiological links between infections occurring in these countries was reported recently. 2 Subsequent reports of NDM-1-producing Gram-negative organisms from Australia, the USA and France with links to the Indian subcontinent give further cause for concern that this resistance is spreading globally. 3 -5 We now report the identification of two bla NDM-1 -positive K. pneumoniae isolates recovered at a hospital in Muscat, Sultanate of Oman.
Materials and methods
Bacterial isolates and susceptibility testing K. pneumoniae isolates 601 and 419 were identified using the API20E system (bioMérieux, Marcy l'Étoile, France). The antibiotic susceptibility of the two isolates and their corresponding E. coli transformants were determined by the disc diffusion technique on Mueller-Hinton agar with b-lactam and non-b-lactam antibiotic discs and interpreted according to the June 2010 updated CLSI guidelines. 6 MICs were determined with Etest strips (AB bioMérieux, Solna, Sweden).
Azide-resistant E. coli J53 (Invitrogen, Cergy-Pontoise, France) was used as the host in conjugation experiments.
PCR amplification and sequencing
PCRs were performed with primers designed for the detection of Ambler class A and B b-lactamase genes. 3, 7 Amplified DNA fragments were purified with the Qiaquick PCR purification kit (Qiagen, Courtaboeuf, France). Both strands of the amplification products obtained were sequenced with an ABI 3100 sequencer (Applied Biosystems, Foster City, CA, USA). The nucleotide and deduced protein sequences were analysed with software available on the internet at the National Center for Biotechnology Information web site (www.ncbi.nlm.nih.gov).
Plasmid analysis
Conjugation assays were performed using K. pneumoniae 601 and 419 isolates as donors and an azide-resistant E. coli J53 as the recipient strain, with selection based on growth on agar in the presence of ceftazidime (30 mg/L) and azide (100 mg/L). Plasmid DNA was extracted using the Kieser method. 8 Plasmid incompatibility groups were determined by a PCR-based replicon typing (PBRT) method as previously described. 9 
Strain genotyping
Multilocus sequence typing (MLST) was performed as described previously 10 in order to determine the sequence types (STs) of the two K. pneumoniae isolates, and to establish a comparison with previously reported NDM-1-producing isolates. In addition, PFGE was performed using the XbaI restriction enzyme to evaluate the clonal relationship between the different NDM-1 producers.
Results and discussion
The first isolate was recovered from a urinary catheter of an Omani patient previously admitted to an Indian hospital (precise location unknown) for pneumonia in March 2009. The patient was transferred to Oman and admitted to the intensive care unit (ICU) where endotracheal secretions grew a multidrug-resistant Acinetobacter baumannii together with a methicillin-resistant Staphylococcus aureus. The patient was treated with meropenem and colistin inhalation for 10 days and recovered. Systematic surveillance for urine colonization identified a multidrug-resistant K. pneumoniae (designated strain 601) that was resistant to all b-lactams including carbapenems (MICs of imipenem, ertapenem and meropenem all .32 mg/L). PCR and sequencing revealed that the isolate harboured the bla NDM-1 gene, with additional b-lactamase genes including the extended-spectrum b-lactamase genes bla CTX-M-15 and bla SHV-28 , and bla OXA-1 , bla OXA-9 and bla TEM-1 . In addition, the armA and aacA4 genes encoding resistance to aminoglycosides were identified. Mating assays identified the bla NDM-1 gene on a 170 kb transferable plasmid. This plasmid (p601) also harboured the armA gene, which co-transferred resistance to all aminoglycosides, and belonged to the IncL/M incompatibility group. The MICs of imipenem, ertapenem and meropenem for an E. coli transconjugant containing p601 were 1, 1 and 0.5 mg/L, respectively.
The second patient, who had been involved in a road traffic accident, was admitted to the same ICU in the autumn of 2009, 3 months after the first patient had left. This patient underwent orthopaedic surgery, and received a 5 day regimen of piperacillin/tazobactam and amikacin following onset of a fever. Again, surveillance of urine showed colonization with a multidrug-resistant K. pneumoniae (strain 419). However, this patient remained asymptomatic and was discharged 3 months later without any other febrile episode. Isolate 419 was resistant to penicillins, cephalosporins, ertapenem (MIC 2 mg/L) and meropenem (MIC 6 mg/L) and had decreased susceptibility to imipenem (MIC 2 mg/L), but was susceptible to aztreonam. 6 It was also resistant to all aminoglycosides, sulphonamides, tetracycline and fluoroquinolones, and remained susceptible only to tigecycline and colistin. Isolate 419 harboured the bla NDM-1 gene with b-lactamase genes bla OXA-1 and bla SHV-11 . In addition, the armA and aacA4 genes encoding resistance to aminoglycosides were identified. Mating assays demonstrated that the bla NDM-1 gene was on a 170 kb transferable plasmid co-harbouring the armA gene as observed for isolate 601. However, the PBRT method did not allow us to determine the Inc type of plasmid p419. An E. coli transconjugant (p419) exhibited imipenem, ertapenem and meropenem MICs of 1, 1 and 0.5 mg/L, respectively. In addition to resistance to b-lactams and aminoglycosides, it was also resistant to trimethoprim.
MLST identified K. pneumoniae 601 as an ST14 strain, which matches the genetic background of the index NDM-1-producing K. pneumoniae isolate originating from India, 1 and of the NDM-1-producing K. pneumoniae isolates recently identified from Kenya (L. Poirel, G. Revathi, S. Bernabeu and P. Nordmann, unpublished data). PFGE analysis confirmed that K. pneumoniae 601 was clonally related to K. pneumoniae 05-506 from India and to NDM-1-producing isolates from Kenya ( Figure 1 ). However, isolate 419 (which was not thought to be an imported strain) was not clonally related by PFGE analysis, and MLST typing revealed that it belonged to ST340, which is significantly different from ST14. This finding suggests that the ST340 clone may have originated from Oman or from another country. K. pneumoniae 419 harboured a bla NDM-1 -positive plasmid (p419), the replicase gene of which was untypeable, thus suggesting that plasmids p419 and p601 were different. To further assess the relationship between the two plasmids, both were analysed by restriction fragment length polymorphisms using different endonucleases. Despite repeated attempts, self-degradation of plasmid p419 did not allow comparison using this technique (data not shown).
This is the first identification of NDM-1 producers in the Arabian peninsula. Interestingly, one of the two isolates was clonally related to the strain previously identified in India, strongly suggesting its importation from India. This further emphasizes that the Indian subcontinent may be an important NDM-1 producers in the Arabian peninsula 305 JAC reservoir of NDM-1. This is especially of concern in the Sultanate of Oman where up to 450000 Indian or Pakistani citizens live.
